Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Tachykinin Neurokinin-2 Receptor (NK2R) is a G protein-coupled receptor that belongs to the tachykinin receptor family. It is primarily activated by the neuropeptide Neurokinin A and plays a crucial role in smooth muscle contraction/relaxation, gastrointestinal motility, airway tone, bladder activity, vasodilation, and immune modulation. NK2R is expressed in peripheral tissues, particularly in the smooth muscle of the respiratory, gastrointestinal, and genitourinary tracts, with limited expression in the central nervous system. NK2 antagonists are being explored as potential treatments for asthma, irritable bowel syndrome (IBS), bladder dysfunction, and anxiety. Altered signaling through NK2R is implicated in various diseases involving smooth muscle dysfunction or neurogenic inflammation.
NK2 receptor antagonism
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tachykinin Neurokinin-2 Receptor (NK2R).